17 PATIENT COUNSELING INFORMATION Advise the patient to read the FDA-approved patient labeling (Patient Information). Embryo-Fetal Toxicity Advise female patients of the potential risks to a fetus. Advise females of reproductive potential to use effective contraception during treatment with VFEND. This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.